NASDAQ:APTO
Delisted

Aptose Biosciences Stock Signals

etoro logo Buy APTO
*Your capital is at risk
$1.71
+0 (+0%)
At Close: Jul 25, 2025

Latest Data & Signals Issued

Below are some of the latest signals issued for Aptose Biosciences

General

Signal Type Signal Value Data
Score 0.000 78 days ( 34.23 %
Last Price $1.71 0 %
Performance History
7 Days
$1.71 $1.71
0%
30 Days
$1.71 $1.71
0%
12 Mos
$17.05 $1.71
-89.97%

3/18

Active Buy Signals

Specific Signals

Short Term
Net score: 5.41
Signal Type Signal Value Importance Data
High / Low N/A Very Low $1.71 - $1.71
Trend - 3 mos -2.09 % High Width: 29.39 %
Pred. range - 3 mos $1.63 - $2.11 Low -4.67 % - 23.34 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Apr 29, 2025 - 61 days
RSI Short Pivot Signal Sell Very Low Nov 30, -0001 - N/A days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 16.93
Signal Type Signal Value Importance Data
Trend - 12 mos -85.85 % Very High Width: 156.33 %
Pred. range - 12 mos N/A - $0.344 High -100.00 % - -79.88 %
Short MA 12 mos Sell Very High Apr 28, 2025 - 62 days
Long MA 12 mos Sell Very High Jun 10, 2025 - 32 days
Short/Long MA 12 mos Sell Very High Jun 10, 2025 - 32 days
Pivot Long Buy Low Apr 29, 2025 - 61 days
RSI Long Pivot Signal Buy Low Apr 21, 2025 - 67 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT APTOSE BIOSCIENCES
Aptose Biosciences
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Ph...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE